Literature DB >> 11320818

[Clinical findings in autosomal recessive syndrome of blue cone hypersensitivity].

B Jurklies1, M Weismann, U Kellner, E Zrenner, N Bornfeld.   

Abstract

BACKGROUND: Intrafamilial variability of the syndrome of night blindness, maculopathy, and enhanced S-cone hypersensitivity was examined. PATIENTS AND METHODS: Siblings with a history of night blindness and reduced visual acuity were examined clinically, psychophysically, electroretinographically (ERG), and electro-oculographically (EOG).
RESULTS: The siblings had had night blindness since early childhood and reduced visual acuity since the age of 20 years. Ophthalmoscopy showed degenerative, pigmented changes and subretinal spots, while one sibling had cystic lesions in the fovea. Scotopic ERG showed no rod-driven responses, while large, slow waveforms were detected in response to bright flashes. Photopic ERG induced responses similar in time, amplitude, and configuration to those of the dark-adapted ERG. The b-wave configuration was unchanged in response to chromatic stimuli. However, photopic ERG was more sensitive to blue and white than to red stimuli. The light peak on EOG was reduced.
CONCLUSIONS: The enhanced S-cone sensitivity syndrome was expressed to a different degree of severity and probably inherited in an autosomal recessive mode. These unusual ERG findings may be due to a depressed rod system and an increased number of S-cone photoreceptors, postreceptoral circuits, and S-cone sensitive ganglion cells.

Entities:  

Mesh:

Year:  2001        PMID: 11320818     DOI: 10.1007/s003470170164

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  1 in total

1.  Differential dimerization of variants linked to enhanced S-cone sensitivity syndrome (ESCS) located in the NR2E3 ligand-binding domain.

Authors:  Désirée von Alpen; Hoai Viet Tran; Nicolas Guex; Giulia Venturini; Francis L Munier; Daniel F Schorderet; Neena B Haider; Pascal Escher
Journal:  Hum Mutat       Date:  2015-04-27       Impact factor: 4.878

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.